Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 107,919 | 32,488 | 158,687 | 136,201 | 85,336 |
| Depreciation Amortization | 11,596 | 5,899 | 24,461 | 17,153 | 11,360 |
| Income taxes - deferred | -7,066 | -3,863 | -7,301 | -14,677 | -10,796 |
| Accounts receivable | -14,208 | -11,435 | -13,754 | -17,618 | -9,948 |
| Accounts payable and accrued liabilities | 3,991 | 10,907 | 3,949 | 12,597 | 14,557 |
| Other Working Capital | -45,380 | -49,632 | 91,817 | 17,780 | -12,362 |
| Other Operating Activity | 63,340 | 43,396 | 90,340 | 70,612 | 35,167 |
| Operating Cash Flow | $120,192 | $27,760 | $348,199 | $222,048 | $113,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -310 | -203 | -132 |
| Purchase Of Investment | -331,529 | -178,995 | -86,151 | -67,313 | -43,032 |
| Sale Of Investment | 48,380 | 27,349 | 81,062 | 60,500 | 40,937 |
| Other Investing Activity | -32,000 | -32,000 | -34,250 | -15,000 | -15,000 |
| Investing Cash Flow | $-315,149 | $-183,646 | $-39,649 | $-22,016 | $-17,227 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,000 | -5,000 | -16,250 | -11,250 | -7,500 |
| Common Stock Issued | 5,864 | 347 | 10,205 | 7,557 | 6,803 |
| Other Financing Activity | -3,640 | -2,565 | -3,004 | -2,341 | -2,341 |
| Financing Cash Flow | $-7,776 | $-7,218 | $-9,049 | $-6,034 | $-3,038 |
| Beginning Cash Position | 752,772 | 752,772 | 453,271 | 453,271 | 453,271 |
| End Cash Position | 550,039 | 589,668 | 752,772 | 647,269 | 546,320 |
| Net Cash Flow | $-202,733 | $-163,104 | $299,501 | $193,998 | $93,049 |
| Free Cash Flow | |||||
| Operating Cash Flow | 120,192 | 27,760 | 348,199 | 222,048 | 113,314 |
| Capital Expenditure | 0 | 0 | -310 | -203 | -132 |
| Free Cash Flow | 120,192 | 27,760 | 347,889 | 221,845 | 113,182 |